SCHEMBL27190092

SCHEMBL27190092

CCOC(=O)c1cnc2c(O)c([N+](=O)[O-])ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.53
KMT2A Q03164 2/20 0.46
GSTP1 P09211 2/20 0.46
GSTM2 P28161 2/20 0.46
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
RAB9A P51151 4/20 0.46
NPC1 O15118 4/20 0.46
PKM P14618 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
NFKB1 P19838 1/20 0.45
MAPK1 P28482 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.43
PTGER4 P35408 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30122666 0.87 MAOB (0.52) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL29126347 0.87 MAOB (0.52) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL25249261 0.81 KMT2A (0.49) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL26793959 0.78 KMT2A (0.53) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL29907140 0.78 KMT2A (0.53) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL27190042 0.77 CCR1 (0.55) KMT2AALDH1A1MAPTPKMNFKB1
SCHEMBL30792561 0.77 CCR1 (0.55) KMT2AALDH1A1MAPTPKMNFKB1
SCHEMBL29377788 0.76 ALDH1A1 (0.47) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL25247941 0.76 ALDH1A1 (0.47) MAOBKMT2AGSTP1GSTM2ALDH1A1
SCHEMBL710164 0.76 NPC1 (0.53) MAOBKMT2AALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 MAOB 871/4885KMT2A 2738/4885GSTP1 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.